{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:05Z","timestamp":1786991165160,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"NHGRI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jacadv.2026.102687","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:09:57Z","timestamp":1773925797000},"page":"102687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events"],"prefix":"10.1016","volume":"5","author":[{"given":"Jiwoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R.","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-3650","authenticated-orcid":false,"given":"Jennifer L.","family":"Halford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Mi","family":"Jemma Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Dron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haidermota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-9647","authenticated-orcid":false,"given":"Sarah","family":"Urbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buu","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-7435","authenticated-orcid":false,"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ahj.2014.03.001","article-title":"Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice","volume":"167","author":"Patel","year":"2014","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102687_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2021.06.025","article-title":"Atherosclerotic renovascular disease: a KDIGO (Kidney disease: improving global outcomes) controversies conference","volume":"79","author":"Hicks","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"3 Suppl","key":"10.1016\/j.jacadv.2026.102687_bib3","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"issue":"1S","key":"10.1016\/j.jacadv.2026.102687_bib4","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/j.jvs.2021.04.073","article-title":"Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J Vasc Surg"},{"issue":"17","key":"10.1016\/j.jacadv.2026.102687_bib5","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/CIRCULATIONAHA.110.001404","article-title":"Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin\u2013Coronary Artery Disease Trial","volume":"123","author":"Wiviott","year":"2011","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacadv.2026.102687_bib6","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.97.15.1446","article-title":"Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial","volume":"97","author":"Sacks","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib7","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1038\/s41598-017-03062-8","article-title":"Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure","volume":"7","author":"Verweij","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jacadv.2026.102687_bib8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jacc.2022.08.767","article-title":"Biomarker-based prediction of recurrent ischemic events in patients with acute coronary syndromes","volume":"80","author":"Batra","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102687_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001646","article-title":"Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the heart and soul study","volume":"4","author":"Beatty","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jcmg.2018.01.021","article-title":"High-sensitivity troponin I and coronary computed tomography in symptomatic outpatients with suspected CAD: insights from the PROMISE trial","volume":"12","author":"Januzzi","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"41","key":"10.1016\/j.jacadv.2026.102687_bib11","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1093\/eurheartj\/ehaa648","article-title":"Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention","volume":"41","author":"Hoogeveen","year":"2020","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacadv.2026.102687_bib12","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/CIRCULATIONAHA.118.034365","article-title":"Proteomic architecture of human coronary and aortic atherosclerosis","volume":"137","author":"Herrington","year":"2018","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.jacadv.2026.102687_bib13","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/eurheartj\/ehad380","article-title":"Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study","volume":"44","author":"Cho","year":"2023","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jacadv.2026.102687_bib14","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.102687_bib15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s44161-024-00567-0","article-title":"Integrative proteomic analyses across common cardiac diseases yield new mechanistic insights and enhanced prediction","volume":"3(12)","author":"Schuermans","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"7726","key":"10.1016\/j.jacadv.2026.102687_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102687_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.123.22160","article-title":"Cumulative diastolic blood pressure burden in normal systolic blood pressure and cardiovascular disease","volume":"81","author":"Cho","year":"2024","journal-title":"Hypertension"},{"issue":"7982","key":"10.1016\/j.jacadv.2026.102687_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102687_bib19","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.jacadv.2026.102687_bib20","doi-asserted-by":"crossref","first-page":"D262","DOI":"10.1093\/nar\/gkh021","article-title":"The Gene Ontology Annotation (GOA) database: sharing knowledge in uniprot with gene ontology","volume":"32","author":"Camon","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102687_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMoa2405923","article-title":"Routine spironolactone in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jacadv.2026.102687_bib22","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1073\/pnas.070036297","article-title":"Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction","volume":"97","author":"Kurrelmeyer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacadv.2026.102687_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2018.03.020","article-title":"Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden","volume":"272","author":"Carlsson","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacadv.2026.102687_bib24","article-title":"PTEN gene & TNF-alpha in acute myocardial infarction","volume":"23","author":"Mahmoud","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacadv.2026.102687_bib25","series-title":"TNFR2 Non-Canonical NF-kB Pathway","author":"Garapati","year":"2015"},{"key":"10.1016\/j.jacadv.2026.102687_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1206541","article-title":"A novel therapeutic vaccine targeting the soluble TNF\u03b1 receptor II to limit the progression of cardiovascular disease: atherovax\u2122","volume":"10","author":"Iversen","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102687_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/cvp274","article-title":"Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway","volume":"84","author":"Lacerda","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102687_bib28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/stem.1433","article-title":"TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease","volume":"31","author":"Al-Lamki","year":"2013","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102687_bib29","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1111\/j.1600-6143.2009.02831.x","article-title":"TNF receptors differentially signal and are differentially expressed and regulated in the human heart","volume":"9","author":"Al-Lamki","year":"2009","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102687_bib30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cells11071249","article-title":"Early protective role of inflammation in cardiac remodeling and heart failure: focus on TNF\u03b1 and resident macrophages","volume":"11","author":"Besse","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.jacadv.2026.102687_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor necrosis Factor-\u03b1 in heart failure: an updated review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib32","first-page":"18","article-title":"Tumor necrosis factor-\u03b1 and its role as a mediator in myocardial infarction: a brief review","volume":"1","author":"Tian","year":"2015","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.jacadv.2026.102687_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.11.001","article-title":"Non-canonical NF-\u03baB contributes to endothelial pyroptosis and atherogenesis dependent on IRF-1","volume":"255","author":"Fan","year":"2023","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.jacadv.2026.102687_bib35","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/ATVBAHA.107.155143","article-title":"Death receptors and their ligands in atherosclerosis","volume":"28","author":"Kavurma","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacadv.2026.102687_bib36","article-title":"NF-\u03baB and its crosstalk with endoplasmic reticulum stress in atherosclerosis","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102687_bib37","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2353\/ajpath.2006.060603","article-title":"Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis","volume":"169","author":"Luo","year":"2006","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.jacadv.2026.102687_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12012-014-9257-z","article-title":"Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox","volume":"14","author":"Cacciapaglia","year":"2014","journal-title":"Cardiovasc Toxicol"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102687_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008299","volume":"7","author":"Carlsson","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2014.09.005","article-title":"Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly","volume":"237","author":"Carlsson","year":"2014","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102687_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00380-006-0910-8","article-title":"Inflammatory markers in a 2-year follow-up of coronary artery disease","volume":"21","author":"Mizia-Stec","year":"2006","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1096\/fj.04-2073fje","article-title":"Soluble Tumor Necrosis Factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1","volume":"19","author":"Waetzig","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jacadv.2026.102687_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.576152","article-title":"Clinical significance of serum soluble TNF receptor I\/II ratio for the differential diagnosis of tumor necrosis factor receptor-associated periodic syndrome from other autoinflammatory diseases","volume":"11","author":"Yasumura","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/ATVBAHA.118.312166","article-title":"Circulating TNFSF14 (tumor necrosis factor superfamily 14) predicts clinical outcome in patients with stable coronary artery disease","volume":"39","author":"Hsu","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jdv.20017","article-title":"TNF inhibitors and cardiovascular risk: friend or foe?","volume":"38","author":"Gelfand","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jacadv.2026.102687_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113861","article-title":"Sex differences in proatherogenic cytokine levels","volume":"21","author":"Bernardi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2013.10.042","article-title":"Gender difference in tumor necrosis factor-\u03b1 production in human neutrophils stimulated by lipopolysaccharide and interferon-\u03b3","volume":"441","author":"Aomatsu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.humimm.2015.03.018","article-title":"Higher TNF\u03b1 responses in young males compared to females are associated with attenuation of monocyte adenylyl cyclase expression","volume":"76","author":"Ris\u00f8e","year":"2015","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/hs0102.100531","article-title":"Tumor necrosis factor receptor levels are associated with carotid atherosclerosis","volume":"33","author":"Elkind","year":"2002","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2353\/ajpath.2007.060708","article-title":"Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging","volume":"170","author":"Csiszar","year":"2007","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102687_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.004681","article-title":"Dynamic importance of genomic and clinical risk for coronary artery disease over the life course","volume":"18","author":"Urbut","year":"2025","journal-title":"Circ Genom Precis Med"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102687_bib52","article-title":"Tumor necrosis factor-alpha inhibitors and cardiovascular risk in rheumatoid arthritis: a systematic review","volume":"14","author":"Nair","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.jacadv.2026.102687_bib53","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jdv.20786","article-title":"Evaluation of the risk of heart failure with tumour necrosis factor inhibitors: a large-scale meta-analysis in immune-mediated inflammatory diseases","volume":"39","author":"Galajda","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:06:46Z","timestamp":1784934406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2772963X26001055"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102687","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102687"}}